Mark Barker, Author at Journal for Clinical Studies - Page 194 of 338

Current Edition

Volume 17 Issue 3

Europe

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer

Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for th...

1 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Retrospective Study Featuring OSSDSIGN® Cranial Published in World Neurosurgery

UPPSALA, Sweden, October 29, 2018 (Newswire.com) - OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial rec...

1 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Pivotal Trial Confirms Long-Term Safety and Efficacy of IV Iron Dosing Strategy

Results from the PIVOTAL trial were presented during the High-Impact Clinical Trials session at American Society of Nephrology (ASN) Kidney Week 2018 The tria...

1 November 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

Genmab Announces Positive Topline Results in Phase III MAIA Study of Daratumumab in Front Line Multiple Myeloma

Phase III MAIA study of daratumumab in combination with lenalidomide and dexamethasone in front line multiple myeloma met the primary endpoint (PFS) at a pre-plann...

1 November 2018 Europe | news | Regional News

Continue Reading →

US Enhances Malaria-fighting Toolkit

Volume 10 Issue 5

US Enhances Malaria-fighting Toolkit

The (FDA) asked an advisory committee to meet twice in two weeks to discuss nearly identical products with similar indications from two different pharmaceutical compa...

25 October 2018 Volume 10 Issue 5

Continue Reading →

Innovative Approaches in Early-phase and First in Human Clinical Trials

Volume 10 Issue 5

Innovative Approaches in Early-phase and First in Human Clinical Trials

There are many challenges that clinical research may face, and there is a risk of failure along the many phases of development. For a trial designer, there are many i...

25 October 2018 Volume 10 Issue 5

Continue Reading →

Harnessing Social Media to Reach Today’s Social Media-savvy Rare Disease Patient and Caregiver

Volume 10 Issue 5

Harnessing Social Media to Reach Today’s Social Media-savvy Rare Disease Patient and Caregiver

For patients with rare diseases, social media conversations are a gateway to uncovering information regarding condition coping and treatment. Likewise, for those who ...

25 October 2018 Volume 10 Issue 5

Continue Reading →

An Interprofessional Model for Cardiac Safety Education

Volume 10 Issue 5

An Interprofessional Model for Cardiac Safety Education

Since its formalisation in 2006, the Cardiac Safety Research Consortium (CSRC) has facilitated research projects, think tanks, and many publications in medical and sc...

25 October 2018 Volume 10 Issue 5

Continue Reading →

Diabetes Research Using New Data Models Makes Fresh Research Connections

Volume 10 Issue 5

Diabetes Research Using New Data Models Makes Fresh Research Connections

The emergence of Big Data and other advances in data science approaches and tools are providing medical researchers with the opportunity for previously unobtainable i...

25 October 2018 Volume 10 Issue 5

Continue Reading →

Pharmacovigilance in the European Union

Volume 10 Issue 5

Pharmacovigilance in the European Union

In 2012, the European Union (EU) introduced regulatory controls for good pharmacovigilance practices (GVPs) to its member states. Since then, pharma businesses operat...

25 October 2018 Volume 10 Issue 5

Continue Reading →